Despite gaining market share in Japan, the company's sales dropped by double-digits for the third consecutive quarter due to COVID and price reductions.
The company's revenue declined -7.4% in 3Q20 as capital sales remain slow, and the lack of team sports activity depresses sports medicine procedure volumes.